<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.447  Clindamycin solution.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter of solution contains the  equivalent of 25 milligrams (mg) clindamycin as the hydrochloride salt.</p><p class="depth1"><em>(b)</em> Sponsors. See Nos. 000859, 051311, 054771, 058829, and 061623 in  Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Special considerations. Federal law restricts this drug to use  by or on the order of a licensed veterinarian.</p><p class="depth1"><em>(d)</em> Conditions of use--</p><p class="depth2"><em>(1)</em> Dogs--</p><p class="depth3"><em>(i)</em> Amount. Wounds, abscesses, and  dental infections: 2.5 to 15 mg per pound (/lb) body weight every 12  hours for a maximum of 28 days. Osteomyelitis: 5.0 to 15 mg/lb body  weight every 12 hours for a minimum of 28 days.</p><p class="depth3"><em>(ii)</em> Indications for use. For the treatment of skin infections  (wounds and abscesses) due to susceptible strains of coagulase-positive  staphylococci (Staphylococcus aureus or S. intermedius), deep wounds and  abscesses due to susceptible strains of Bacteroides fragilis, Prevotella  melaninogenicus, Fusobacterium necrophorum, and Clostridium perfringens;  dental infections due to susceptible strains of S. aureus, B. fragilis,  P. melaninogenicus, F. necrophorum, and C. perfringens; and  osteomyelitis due to susceptible strains of S. aureus, B. fragilis, P.  melaninogenicus, F. necrophorum, and C. perfringens.</p><p class="depth2"><em>(2)</em> Cats--</p><p class="depth3"><em>(i)</em> Amount. 5.0 to 15.0 mg/lb body weight every 24 hours  for a maximum of 14 days.</p><p class="depth3"><em>(ii)</em> Indications for use. For the treatment of skin infections  (wounds and abscesses) due to susceptible strains of Staphylococcus  aureus, S. intermedius, Streptococcus spp.; deep wounds and abscesses  due to susceptible strains of Clostridium perfringens and Bacteroides  fragilis; and dental infections due to susceptible strains of S. aureus,  S. intermedius, Streptococcus spp., C. perfringens, and B. fragilis.  [67 FR 54954, Aug. 27, 2002, as amended at 67 FR 78684, Dec. 26, 2002;  68 FR 55824, Sept. 29, 2003; 69 FR 31734, June 7, 2004; 71 FR 39543,  July 13, 2006; 72 FR 19796, Apr. 20, 2007; 78 FR 17596, Mar. 22, 2013;  78 FR 30197, May 22, 2013; 79 FR 28819, May 20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
